- Home
- VSTM vs GUG Comparison
VSTM vs GUG Comparison
Compare VSTM & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- GUG
- Stock Information
- Founded
- VSTM 2010
- GUG 2021
- Country
- VSTM United States
- GUG United States
- Employees
- VSTM N/A
- GUG N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- GUG Trusts Except Educational Religious and Charitable
- Sector
- VSTM Health Care
- GUG Finance
- Exchange
- VSTM Nasdaq
- GUG Nasdaq
- Market Cap
- VSTM 581.6M
- GUG 524.4M
- IPO Year
- VSTM 2012
- GUG N/A
- Fundamental
- Price
- VSTM $8.00
- GUG $15.46
- Analyst Decision
- VSTM Strong Buy
- GUG
- Analyst Count
- VSTM 9
- GUG 0
- Target Price
- VSTM $13.38
- GUG N/A
- AVG Volume (30 Days)
- VSTM 2.9M
- GUG 108.9K
- Earning Date
- VSTM 11-04-2025
- GUG 01-01-0001
- Dividend Yield
- VSTM N/A
- GUG 9.67%
- EPS Growth
- VSTM N/A
- GUG N/A
- EPS
- VSTM N/A
- GUG N/A
- Revenue
- VSTM $13,379,000.00
- GUG N/A
- Revenue This Year
- VSTM $88.60
- GUG N/A
- Revenue Next Year
- VSTM $416.99
- GUG N/A
- P/E Ratio
- VSTM N/A
- GUG N/A
- Revenue Growth
- VSTM 33.79
- GUG N/A
- 52 Week Low
- VSTM $3.46
- GUG $12.71
- 52 Week High
- VSTM $11.25
- GUG $15.06
- Technical
- Relative Strength Index (RSI)
- VSTM 43.46
- GUG 40.28
- Support Level
- VSTM $7.55
- GUG $15.27
- Resistance Level
- VSTM $10.09
- GUG $15.55
- Average True Range (ATR)
- VSTM 0.64
- GUG 0.27
- MACD
- VSTM -0.09
- GUG -0.05
- Stochastic Oscillator
- VSTM 16.54
- GUG 25.89
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.